Company Active PLC

Company profile

Smith & Nephew PLC

Smith+Nephew Medical Devices and Advanced Wound Care | Global

Smith+Nephew is a global portfolio medical technology business. We design and make technology that takes the limits off living.

CRN
00324357
Founded
1937
Age
89

Overview

Legal name
SMITH & NEPHEW PLC
Region
East of England
Registered address
BUILDING 5, CROXLEY PARK
HATTERS LANE
WATFORD
HERTFORDSHIRE
ENGLAND
WD18 8YE
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Smith & Nephew PLC
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

16 events
14 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2026

Accounts due

Accounts Due

Next accounts due date

23 Jun
2026

Memorandum Articles

Incorporation

MA | Transaction MzUyNjQzMTQ2NWFkaXF6a2N4 | Paper/PDF filed

Published 23 Jun 2026 22:58

23 Jun
2026

Resolution

Resolution

RESOLUTIONS | Transaction QUYzWUxNMFJhZGlxemtjeA | Paper/PDF filed

Published 23 Jun 2026 22:50

27 May
2026

Capital Sale Or Transfer Treasury Shares With Date Currency Capital Figure

Capital

SH04 | Transaction MzUyMDMxMTQ4OGFkaXF6a2N4 | Paper/PDF filed

Published 27 May 2026 23:01

27 May
2026

Capital Sale Or Transfer Treasury Shares With Date Currency Capital Figure

Capital

SH04 | Transaction MzUyMTUyMjUyNGFkaXF6a2N4 | Paper/PDF filed

Published 27 May 2026 08:52

21 May
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUyMDMwODM3N2FkaXF6a2N4 | Paper/PDF filed

Published 22 May 2026 22:48

02 Apr
2026

Capital Sale Or Transfer Treasury Shares With Date Currency Capital Figure

Capital

SH04 | Transaction MzUxMTk4NjE4M2FkaXF6a2N4 | Paper/PDF filed

Published 02 Apr 2026 23:27

28 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

28 Oct
2024

Capital Sale Or Transfer Treasury Shares With Date Currency Capital Figure

Capital

SH04 | Transaction MzQ0MDQ2MDgzMWFkaXF6a2N4 | Paper/PDF filed

Published 30 Oct 2024 07:09

25 Sep
2024

Capital Sale Or Transfer Treasury Shares With Date Currency Capital Figure

Capital

SH04 | Transaction MzQzNjY5MjA1NGFkaXF6a2N4 | Paper/PDF filed

Published 26 Sep 2024 06:34

25 Sep
2024

Capital Sale Or Transfer Treasury Shares With Date Currency Capital Figure

Capital

SH04 | Transaction MzQzNjY5MjA1NWFkaXF6a2N4 | Paper/PDF filed

Published 26 Sep 2024 06:29

22 Sep
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzNjY5MjA1NmFkaXF6a2N4 | Paper/PDF filed

Published 24 Sep 2024 06:58

29 Jul
2024

Capital Sale Or Transfer Treasury Shares With Date Currency Capital Figure

Capital

SH04 | Transaction MzQyOTk1MjUzMGFkaXF6a2N4 | Paper/PDF filed

Published 15 Aug 2024 09:50

17 Feb
1937

Incorporated

Inception

Company registered at Companies House

Public funding

12 awards
First funded
2006
Funded years
2006, 2008, 2009
Age at first award
69 years

Projects

2009 Collaborative R&D Lead participant

Device for Enrichment of Skeletal Stem Cells for Orthopaedic Applications

1 Mar 2009 to 28 Feb 2011

Awarded
£75,074
Total cost £636,756

Awaiting Public Summary

2008 Collaborative R&D Lead participant

Digital Multi-channel Tibial Implants in Orthopedic Medicine

1 Oct 2008 to 30 Jun 2012

Awarded
£22,672
Total cost £932,610

The primary objective of this project is to develop low cost, metal-composite intramedullary (IM) nails for trauma application using high value manufacturing methods such as 3D printing, injection moulding and tape winding processing. Although there are significant patient and surgeon advantages to using composite materials in terms of improved visualizat...

2008 Collaborative R&D Lead participant

The design and manufacture of smart materials for orthopeadic applications

1 Jul 2008 to 30 Sep 2010

Awarded
£288,749
Total cost £993,417

Awaiting Public Summary

2008 Collaborative R&D Lead participant

Smart antibacterial coatings for Orthopaedic implants

1 Apr 2008 to 31 Mar 2011

Awarded
£213,340
Total cost £426,680

Awaiting Public Summary

2008 Collaborative R&D Lead participant

Nanoscale Polymer Ceramic Composites for Biomedical Applications

1 Apr 2008 to 30 Sep 2011

Awarded
£24,782
Total cost £56,050

Awaiting Public Summary

2008 Collaborative R&D Lead participant

High Performance Liquid Crystalline Bioresorbable Polymers

1 Jan 2008 to 31 Dec 2010

Awarded
£452,390
Total cost £904,782

Awaiting Public Summary

2006 Collaborative R&D

Development of an arthroscopic cartilage repair system

1 Dec 2006 to 30 Jun 2012

Awarded
£264,833
Total cost £602,864

The Leeds cartilage repair system provides a disease-modifying, minimally-invasive cartilage resurfacing therapy for patients whose articular disease is too severe for palliative treatment alone but who are too young to receive joint replacement implants. It consists of a biomaterial implant that features (i) a flexible and hence joint-contour-following s...

2006 Collaborative R&D Lead participant

Development of a reabsorbable composite for orthapaedic trauma applictaions

1 Nov 2006 to 31 Oct 2008

Awarded
£385,486
Total cost £770,972

Awaiting Public Summary

2006 Collaborative R&D Lead participant

A Novel Bioadhesive Cement (BIOAD)

1 Oct 2006 to 30 Sep 2010

Awarded
£103,610
Total cost £372,430

Awaiting Public Summary

2006 Collaborative R&D Lead participant

Enhancing the integration of tissue engineered cartilage during joint repair

1 Oct 2006 to 30 Sep 2009

Awarded
£28,519
Total cost £317,796

Awaiting Public Summary

2006 Collaborative R&D Lead participant

Small Orthapedic Implants

1 Aug 2006 to 30 Sep 2008

Awarded
£187,750
Total cost £375,499

Awaiting Public Summary

2006 Collaborative R&D

Process Development and Scale up of a novel wound healing using dermal stem cells

1 May 2006 to 30 Apr 2009

Awarded
£0
Total cost £3,971

Awaiting Public Summary

Product types

Collaborative R&D